START (South Texas Accelerated Research Therapeutics) is a clinical research site located in San Antonio, Texas, United States 78229.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
START (South Texas Accelerated Research Therapeutics) has participated in 5 clinical trials.
Therapeutic areas: Advanced Solid Tumor, Cancer, Solid Tumor.
Sponsors: 1200 Pharma, LLC, Calando Pharmaceuticals, Kezar Life Sciences, Inc..
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
START (South Texas Accelerated Research Therapeutics) has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
START (South Texas Accelerated Research Therapeutics) has 5 clinical trials on record. Their work covers Advanced Solid Tumor, Cancer, Solid Tumor.
Yes — START (South Texas Accelerated Research Therapeutics) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.